156 related articles for article (PubMed ID: 22563213)
1. Prognostic significance of angiogenesis by Chalkley counting in node negative cancer of the ampulla of Vater.
Park JS; Kim HK; Hong SW; Kim JK; Yoon DS
J Korean Med Sci; 2012 May; 27(5):495-9. PubMed ID: 22563213
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
3. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
5. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater.
Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Wakiyama S; Ishida Y; Yanaga K
Anticancer Res; 2013 Jun; 33(6):2715-21. PubMed ID: 23749931
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of carcinoma of the ampulla of Vater after surgery.
Zhou J; Zhang Q; Li P; Shan Y; Zhao D; Cai J
Tumour Biol; 2014 Feb; 35(2):1143-8. PubMed ID: 24026886
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.
Hansen S; Grabau DA; Sørensen FB; Bak M; Vach W; Rose C
Clin Cancer Res; 2000 Jan; 6(1):139-46. PubMed ID: 10656442
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
Dhakal HP; Bassarova A; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Giercksky KE; Nesland JM
Histol Histopathol; 2009 Aug; 24(8):1049-59. PubMed ID: 19554512
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
10. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.
Shyr YM; Su CH; Wu LH; Li AF; Chiu JH; Wu CW; Lui WY
Ann Surg; 1999 Apr; 229(4):523-7. PubMed ID: 10203085
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum CA19-9 as a prognostic factor for the ampulla of Vater carcinoma.
Kurihara C; Yoshimi F; Sasaki K; Iijima T; Kawasaki H; Nagai H
Hepatogastroenterology; 2013 Oct; 60(127):1588-91. PubMed ID: 23933785
[TBL] [Abstract][Full Text] [Related]
13. Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.
Lee JH; Lee KG; Ryou H; Jun YJ; Paik SS; Park HK; Lee KS
Hepatogastroenterology; 2010; 57(99-100):646-52. PubMed ID: 20698243
[TBL] [Abstract][Full Text] [Related]
14. [Predictors of recurrence after pancreaticoduodenectomy for carcinoma of the ampulla of Vater].
Chen J; Cai S; Dong J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1242-4. PubMed ID: 22985555
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater.
Mizuno T; Ishizaki Y; Ogura K; Yoshimoto J; Kawasaki S
Br J Surg; 2006 Feb; 93(2):221-5. PubMed ID: 16363020
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and operative factors for prognosis of carcinoma of the ampulla of vater.
Inoue Y; Hayashi M; Hirokawa F; Egashira Y; Tanigawa N
Hepatogastroenterology; 2012; 59(117):1573-6. PubMed ID: 22683975
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis.
Dumitrascu T; Dima S; Herlea V; Tomulescu V; Ionescu M; Popescu I
Langenbecks Arch Surg; 2012 Aug; 397(6):933-43. PubMed ID: 22476195
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of solitary lymph node metastasis in carcinoma of the ampulla of Vater].
Shan Y; Zhao DB; Che X; Wang JX; Shao YF; Zhao P
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):694-6. PubMed ID: 17274378
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater.
Chen L; Tao SF; Zheng YX
Hepatogastroenterology; 2006; 53(67):45-50. PubMed ID: 16506374
[TBL] [Abstract][Full Text] [Related]
20. p53 protein accumulation in tumors of the ampulla of Vater.
Younes M; Riley S; Genta RM; Mosharaf M; Mody DR
Cancer; 1995 Oct; 76(7):1150-4. PubMed ID: 8630891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
